Status:
UNKNOWN
Accelerated Continue Theta-burst Stimulation (acTBS)Treatment for Obsessive Compulsive Disease
Lead Sponsor:
Anhui Medical University
Conditions:
Obsessive-Compulsive Disorder
Accelerated Continue Theta-burst Stimulation
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
The therapeutic effects of high-dose accelerated continue theta-burst stimulation (acTBS) and 1-Hz repetitive transcranial magnetic stimulation (rTMS) on obsessive-compulsive disorder (OCD) and its ne...
Detailed Description
All patients underwent a medical evaluation that included physical examination and routine laboratory studies before and after transcranial magnetic stimulation (rTMS) treatment. Patients were randoml...
Eligibility Criteria
Inclusion
- Clinical diagnosis of obsessive-compulsive disorder
- Voluntarily participated and cooperated with the experiment.
Exclusion
- History of significant head trauma or neurological disorders.
- Alcohol or drug abuse.
- Organic brain defects on T1 or T2 images.
- History of seizures or unexplained loss of consciousness.
- Family history of medication refractory epilepsy.
- Recent aggression or other forms of behavioral dyscontrol.
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05221632
Start Date
March 1 2021
End Date
July 1 2023
Last Update
April 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Anhui Medical University
Hefei, Anhui, China, 230032